Figure 7. Wnt5a regulates proliferation of VZ and RL progenitors in discrete manner during embryonic and postnatal development.
(A–D) Immunostaining with proliferation marker Ki67 at E14.5. (E) Graph shows the quantification of Ki67+ve cells at E14.5. (F–I) Image shows Ki67 staining at PN1 stage in Wnt5a cKO and control. (J) Graph shows the quantification of Ki67+ve cells at PN1. (K–N) Immunostaining with PH3 at PN1. (O) Schematic indicates the area represented in the image (K–N). (P) Graph indicates quantification of PH3+ve cells. (Q–T) Image shows Ki67 staining at PN7 stage in Wnt5a cKO and control. (U) Schematic indicates the area represented in the image (Q–T). (V) Graph indicates quantification of Ki67+ve cells. (W–X) Immunohistochemical analysis with Cyclin D1 in sagittal sections (PN1) of Wnt5af/f control and Nestin-Cre; wnt5af/f cKO (w’ & x’) represents specific magnified area of W and X. (Y) Graph indicates the quantification of Cyclin D1+ve cells at PN1. (Z–Aa) Immunostaining with Ki67 in E18.5 Wnt5a+/+ control and Wnt5a−/− null mutants. (Ab) Graph indicates quantification of Ki67+ve cells both in PWM and EGL of Wnt5a+/+ and Wnt5a−/− null mutants. Image (F–I) and (W–X) were generated by stitching together multiple images using Photoshop software. Data expressed as Mean ± SD, n = 3. Scale Bar = 25 μm (A–D,F–I,K–N & Q–T), 50 μm (W–X & Z–Aa).